Narcolepsy

Neurology

Volumn 42, Issue 7, 1992, Pages 34-43

  Aldrich, Michael S ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROUSAL; HUMAN; NARCOLEPSY; PEDIGREE; PHYSIOLOGY; PREVALENCE; REVIEW; SLEEP;

AROUSAL; HUMAN; NARCOLEPSY; PEDIGREE; PREVALENCE; SLEEP;

EID: 0026885339     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: None     Document Type: Article

References (100)

1. Gelineau JBE. De la narcolepsie. Gaz Hop 1880;53:626-628.
2. Adie WJ. Idiopathic narcolepsy: a disease sui generis, with remarks on the mechanisms of sleep. Brain 1926;49:257- 306.
3. Wilson SAK. The narcolepsies. Brain 1928;51:63-109.
4. Yoss RE, Daly D. Criteria for the diagnosis of the narcoleptic syndrome. Proc Staff Meet Mayo Clin 1957;32:320-328.
5. Rechtschaffen A, Wolpert EA, Dement WC, et al. Nocturnal sleep of narcoleptics. Electroencephalogr Clin Neurophysiol 1963;15:599-609.
6. Dement W, Rechtschaffen A, Gulevich G. The nature of the narcoleptic sleep attack. Neurology 1966;16:18-33.
7. Takahashi Y, Jimbo M. Polygraphic study of narcoleptic syndrome, with special reference to hypnagogic hallucinations and cataplexy. Folia Psychiatr Neurol Jpn 1963;7(suppl): 343-347.
8. Vogel G. Studies in psychophysiology of dreams. III. The dream of narcolepsy. Arch Gen Psychiatry 1960;3:421-428.
9. Lavie P, Peled R. Narcolepsy is a rare disease in Israel. Sleep 1987;10:608-609.
10. Honda Y. Census of narcolepsy, cataplexy, and sleep life among teenagers in Fujisawa city [abstractl. Sleep Res 1979; 8:191.
11. Dement W, Zarcone V, Varner V, et al. The prevalence of narcolepsy. In: Chase MH, Stern WC, Walter PL, eds. Sleep Research, vol 1. Los Angeles: Brain Information Service/Brain Research Institute, UCLA:148.
12. Rosenthal L, Zorick F, Merlotti L, et al. Signs and symptoms associated with cataplexy in narcolepsy patients. Biol Psychiatry 1990;27:1057-1060.
13. Billiard M, Besset A, Cadilhac J. The clinical and polygraphic development of narcolepsy. In: Guilleminault C, Lugaresi E, eds. Sleep-wake Disorders: Natural History, Epidemiology, and Long-term Evolution. New York: Raven Press, 1983:171-185.
14. Honda Y, Juji T, Matsuki K, et al. HLA-DR2 and Dw2 in narcolepsy and in other disorders of excessive somnolence without cataplexy. Sleep 1986;9:133-142.
15. Roehrs T, Zorick F, Sicklesteel J, et al. Excessive daytime sleepiness associated with insufficient sleep. Sleep 1983;6: 319-325.
16. Guilleminault C, Mondini S. Mononucleosis and chronic daytime sleepiness. A long-term follow-up study. Arch Intern Med 1986;146:1333-1335.
17. Juji T, Matsuki K, Tokunaga K, et al. Narcolepsy and HLA in the Japanese. Ann N Y Acad Sci 1988;540:106-114.
18. Aldrich MS, Naylor MW. Narcolepsy associated with lesions of the diencephalon. Neurology 1989;39:1505-1508.
19. Broughton R, Ghanem Q, Hishikawa Y, et al. Life effects of narcolepsy in 180 patients from North America, Asia, and Europe compared to matched controls. Can J Neurol Sci 1981;8:299-304.
20. Aldrich MS. Automobile accidents in patients with sleep disorders. Sleep 1989;12:487-494.
21. Broughton R, Guberman A, Roberts J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia 1984;25:423-433.
22. Kales A, Soldatos CR, Bixler EO, et al. Narcolepsy-cata- plexy. II. Psychosocial consequences and associated psychopathology. Arch Neurol 1982;39:169-171.
23. Douglass AB, Hays P, Pazderka F, et al. Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy. J Nerv Ment Dis 1991;179:12-17.
24. Broughton R, Ghanem Q. The impact of compound narcolep-sy in the life of the patient. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. NY: Spectrum, 1976,201-219.
25. Aldrich CK, Aldrich MS, Aldrich TX, et al. Asleep at the wheel: the physician’s role in preventing accidents “just waiting to happen.” Postgrad Med 1986;80:233-240.
26. Nofzinger EA, Thase ME, Reynolds CF III, et al. Hypersomnia in bipolar depression: a comparison with narcolepsy using the multiple sleep latency test. Am J Psychiatry 1991;148:1177-1181.
27. Hartse KM, Zorick FJ, Sicklesteel JM, et al. Isolated cataplexy: a familial study. Henry Ford Hosp Med J 1988;36:24-27.
28. Thorpy MJ and the Diagnostic Classification Steering Committee. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, Minn.: American Sleep Disorders Association, 1990.
29. Richardson GS, Carskadon MA, Flagg W, et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978;45:621-627.
30. Amira SA, Johnson TS, Logowitz NB. Diagnosis of narcolepsy using the multiple sleep latency test: analysis of current laboratory criteria. Sleep 1985;8:325-331.
31. Mitler MM, van den Hoed J, Carskadon MA, et al. REM sleep episodes during the multiple sleep latency test in narcoleptic patients. Electroencephalogr Clin Neurophysiol 1979;46:479-481.
32. Roth B, Bruhova S, Lehovsky M. REM sleep and NREM sleep in narcolepsy and hypersomnia. Electroencephalogr Clin Neurophysiol 1969;26:176-182.
33. Zorick F, Roehrs T, Wittig R, et al. Sleep-wake abnormalities in narcolepsy. Sleep 1986;9:189-193.
34. Thorpy MJ, Wagner DR, Spielman AJ, et al. Objective assessment of narcolepsy. Arch Neurol 1983;40:126-127.
35. Baraitser M, Parkes JD. Genetic study of the narcoleptic syndrome. J Med Genet 1978;15:254-259.
36. Kessler S, Guilleminault C, Dement W. A family study of 50 REM narcoleptics. Acta Neurol Scand 1974;50:503-512.
37. Daly DD, Yoss RE. A family with narcolepsy. Proc Mayo Clin 1959;34:313-319.
38. Krabbe E, Magnussen G. On narcolepsy. I. Familial narcolepsy. Acta Psychiatr Neurol Scand 1942;17:149-173.
39. Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet 1989;2:1376-1379.
40. Juji T, Satake M, Honda Y, et al. HLA antigens in Japanese patients with narcolepsy—all the patients were DR2 positive. Tissue Antigens 1984;24:316-319.
41. Langdon N, Welsh KI, VanDam M, et al. Genetic markers in narcolepsy. Lancet 1984;2:1178-1180.
42. Billiard M, Seignalet J. Extraordinary association between HLA-DR2 and narcolepsy. Lancet 1985;2:226-227.
43. Kramer RE, Dinner DS, Braun WE, et al. HLA-DR2 and narcolepsy. Arch Neurol 1987;44:853-855.
44. Neely S, Rosenberg R, Spire J-P, et al. HLA antigens in narcolepsy. Neurology 1987;37:1858-1860.
45. Olerup O, Schaffer M, Hillert J, et al. The narcolepsy-associated DRwl5, DQw6, Dw2 haplotype has no unique HLA- DQA or -DQB restriction fragments and does not extend to the HLA-DP subregion. Immunogenetics 1990;32:41-44.
46. Honda Y, Matsuki K, Juji T, et al. Recent progress in HLA studies and a genetic model for the development of narcolepsy: recent findings of pathophysiology and genetic research. In: Burton SA, Dement WC, Ristanovic RK, eds. Recent Developments in the Diagnosis and Treatment of Narcolepsy: Selected Proceedings from the Third International Symposium on Narcolepsy. Oak Park, IL: Matrix Communications, 1989;27-29.
47. Rubin RL, Hajdukovich RM, Mitler MM. HLA-DR2 association with excessive somnolence in narcolepsy does not generalize to sleep apnea and is not accompanied by systemic autoimmune abnormalities. Clin Immunol Immunopathol 1988;49:149-158.
48. Holloman JD, Bell JI, Kilduff TS, et al. HLA-DR restriction- fragment-length polymorphisms in narcolepsy. J Neurosci Res 1987;18:239-244.
49. Wilner A, Steinman L, Lavie P, et al. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. Hum Immunol 1988;21:15-22.
50. Uryu N, Maeda M, Nagata Y, et al. No difference in the nucleotide sequence of the DQ(fl)l domain between narcoleptic and healthy individuals with DR2, Dw2. Hum Immunol 1989;24:175-181.
51. Lock CB, So AKL, Welsh KI, et al. MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 1988;27:449-455.
52. Kuwata S, Tokunaga K, Jin F, et al. Narcolepsy [letter]. N Engl J Med 1991;324:271-272.
53. Singh SM, George CFP, Kryger MH, et al. Genetic heterogeneity in narcolepsy. Lancet 1990;335:726-727.
54. Montplaisir J, Poirier G. Narcolepsy in monozygotic twins. Neurology 1987;37:1089.
55. Montplaisir J, Poirier G. Narcolepsy in monozygotic twins. Neurology 1987;37:1089.
56. Ditta SD, George CFP, Singh SM. HLA-D-region genomic DNA restriction fragments in DRwl5(DR2) familial narcolepsy. Sleep 1992;15:48-57.
57. Foutz AS, Delashaw JB, Guilleminault C, et al. Mono- aminergic mechanisms and experimental cataplexy. Ann Neurol 1981;10:369-376.
58. Kushida CA, Baker TL, Dement WC. Electroenceph- alographic correlates of cataplectic attacks in narcoleptic canines. Electroencephalogr Clin Neurophysiol 1985;61:61-70.
59. Mitler MM, Dement WC. Sleep studies on canine narcolepsy: pattern and cycle comparisons between affected and normal dogs. Electroencephalogr Clin Neurophysiol 1977; 43:691-699.
60. Motoyama M, Kilduff TS, Lee BSM, et al. Restriction fragment length polymorphism in canine narcolepsy. Immunogenetics 1989;29:124-126.
61. Dean RR, Kilduff TS, Dement WC, et al. Narcolepsy without unique MHC class II antigen association: studies in the canine model. Hum Immunol 1989;25:27-35.
62. Mignot E, Wang C, Rattazzi C, et al. Genetic linkage of autosomal recessive canine narcolepsy with a p, immunoglobulin heavy-chain switch-like segment. Proc Natl Acad Sci USA 1991;88:3475-3478.
63. Mignot E, Hunt Sharp L, Arrigoni J, et al. Gene dosage effects in canine narcolepsy: induction of cataplexy-like behaviors in heterozygous dogs after drug challenge [abstract]. Sleep Res 1991;20:294.
64. Gaiser C, Burtch M, Radde L, et al. Evidence for an autoimmune etiology in canine cataplexy [abstract]. Sleep Res 1989;18:230.
65. Frederikson S, Carlander B, Billiard M, et al. CSF immune variables in patients with narcolepsy. Acta Neurol Scand 1990;81:253-254.
66. Strohmaier P, Mueller-Eckhardt G, Meier-Ewert K. Cellular approach for detecting narcolepsy-specific alterations in DR2 haplotypes. Hum Immunol 1988;22:221-225.
67. Harris L, Douglass AB, Pazderka F, et al. Patterns of HLA- DR2 inheritance in families with narcolepsy and hypersomnolence [abstract]. Sleep Res 1987;16:347.
68. Hishikawa Y. Sleep paralysis. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. NY: Spectrum, 1975:97124.
69. Schenck CH, Mahowald MH. Motor dyscontrol in narcolepsy: REM without atonia and REM sleep behavior disorder. Ann Neurol 1992 (in press).
70. Broughton R, Valley V, Aguirre M, et al. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep 1986;9:205-215.
71. Siegel JM. Brainstem mechanisms generating REM sleep. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: WB Saunders Co., 1989:104-120.
72. Sakai K. Executive mechanisms of paradoxical sleep. Arch Ital Biol 1988;126:239-257.
73. Baghdoyan HA, Rodrigo-Angulo ML, McCarley RW, et al. Site-specific enhancement and suppression of desynchronized sleep signs following cholinergic stimulation of three brainstem regions. Brain Res 1984;306:39-52.
74. Jones BE. Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 1991;40:637-656.
75. Aldrich MS, Rogers AE. Exacerbation of human cataplexy by prazosin. Sleep 1989;12:254-256.
76. Guilleminault C, Mignot E, Aldrich M, et al. Prazosin contraindicated in patients with narcolepsy. Lancet 1988;2:511.
77. Langdon N, Shindler J, Parkes JD, et al. Fluoxetine in the treatment of cataplexy. Sleep 1986;9:371-373.
78. Montplaisir J, DeChamplain J, Young SN, et al. Narcolepsy and idiopathic hypersomnia: biogenic amines and related compounds in CSF. Neurology 1982;32:1299-1302.
79. Parkes JD, Fenton G, Struthers G, et al. Narcolepsy and cataplexy. Clinical features, treatment, and cerebrospinal fluid findings. Q J Med 1974;43:525-526.
80. Kish SJ, Mamelak M, Slimovitch C, et al. Brain neurotransmitter changes in human narcolepsy. Neurology 1992;42:229-234.
81. Aldrich MS, Hollingsworth Z, Penney JB. Dopamine receptor autoradiography of human narcoleptic brain. Neurology 1992;42:410-415.
82. Aldrich MS, Hollingsworth Z, Penney JB. Adrenergic receptor autoradiography of human narcoleptic brain [abstract]. Sleep Res 1991;20A:280.
83. Mamelak M. A model for narcolepsy. Can J Psychol 1991;45: 194-220.
84. Nishino S, Arrigoni J, Valtier D, et al. Dopamine D2 mechanisms in canine narcolepsy. J Neurosci 1991;11:2666-2771.
85. Nishino S, Haak L, Sheperd H, et al. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. J Pharmacol Exp Ther 1990;253:1145-1152.
86. Renaud A, Nishino S, Arrigoni J, et al. Effects of selective monoamine uptake inhibitors and release enhancers on canine cataplexy [abstract]. Sleep Res 1991;20:76.
87. Kilduff TS, Bowersox SS, Kaitin KI, et al. Muscarinic cholinergic receptors and the canine model of narcolepsy. Sleep 1986;9:102-106.
88. Mignot E, Guilleminault C, Bowersox S, et al. Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep. Brain Res 1989;490:186-191.
89. Fruhstorfer B, Mignot E, Bowersox S, et al. Canine narcolepsy is associated with an elevated number of alpha 2- receptors in the locus coeruleus. Brain Res 1989:500:209-214.
90. Bowersox SS, Kilduff TS, Faull KF, et al. Brain dopamine receptor levels elevated in canine narcolepsy. Brain Res 1987;402:44-48.
91. Guilleminault C, Carskadon M, Dement WC. On the treatment of rapid eye movement narcolepsy. Arch Neurol 1974;30:90-93.
92. Mitler MM, Hajdukovic R. Relative efficacy of drugs for the treatment of sleepiness in narcolepsy. Sleep 1991;14:218-220.
93. Mamelak M, Scharf MB, Woods M. Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings. Sleep 1986;9:285-289.
94. Mignot E, Guilleminault C, Bowersox S, et al. Effect of alpha 1-adrenoceptor blockade with prazosin in canine narcolepsy. Brain Res 1988;444:184-188.
95. Nishino S, Mignot E, Fruhstorfer B, et al. Prostaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy. Proc Natl Acad Sci USA 1989;86:2483-2487.
96. Roehrs T, Zorick F, Wittig R, et al. Alerting effects of naps in patients with narcolepsy. Sleep 1986;9:194-199.
97. Sachs C, Moller E. The occurrence of HLA-DR2 in clinically established narcolepsy. Acta Neurol Scand 1987;75:437-439.
98. Lavie P, Peled R, Brautbar C, et al. Narcolepsy in Israeli Jewish patients is associated with the HLA DR2, DW2 hap- lotype [abstract]. Sleep Res 1986;15:383.
99. Billiard M, Villemin E, Carlander B, et al. Diagnostic criteria of narcolepsy. A reappraisal in view of genetic studies [abstract]. Sleep Res 1991;20:208.
100. Rosenthal LD, Roehrs TA, Hayashi H, et al. HLA typing in narcolepsy without cataplexy [abstract]. Sleep Res 1990;19: 275.